12:00 AM
May 21, 2012
 |  BC Week In Review  |  Company News  |  Deals

Warnex deal

In its 1Q12 earnings, Warnex said it sold its Analytical Services division to its NeoPharm Labs Inc. division for cash proceeds of C$300,000 ($299,100). The Analytical Services division provides quality control services, including...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >